» Articles » PMID: 28542255

Detection of Mycobacterium Tuberculosis from the Stool of HIV Sero-positive Individuals Suspected of Pulmonary Tuberculosis

Overview
Journal PLoS One
Date 2017 May 26
PMID 28542255
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The impact of tuberculosis (TB) is exacerbated in Africa because of the human immunodeficiency virus (HIV) pandemic. Pulmonary tuberculosis (PTB) diagnosis is difficult in HIV-infected patients and negative sputum results are more common which leads to diagnostic delay and increases morbidity and mortality. Extra-pulmonary samples such as stool may be easier to obtain and our approach may therefore significantly improve PTB detection in people living with HIV.

Objective: To detect Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary TB.

Method: A total of 117 HIV-infected individuals from three public health facilities in Addis Ababa, Ethiopia were enrolled consecutively in the study. Paired morning sputum and stool samples were simultaneously collected from anti-retroviral therapy (ART) naïve individuals living with HIV and suspected for PTB. The diagnostic accuracy of the smear microscopy, culture and region of difference (RD)9-based polymerase chain reaction (PCR) in stool was compared with the accuracy of sputum testing. Chi-square test and kappa value were used to compare different method used.

Results: Sputum culture positivity for mycobacteria was confirmed in 33(28.2%) of the study subjects. Of 33 individuals positive for sputa culture, 10 individuals were observed to be stools culture positive. Of the 84 individuals negative for mycobacteria by sputum culture, three (3.6%) were stool culture positive and thus, the sensitivity and agreement between stool culture as compare to sputum culture were 30.3% and 0.33, respectively. Of 117 individuals, 11(9.4%) were sputum smear positive and of 11 sputum smear positive three were also stool smear positive. While of the 106 sputum smear negative individuals', only one was stool smear positive resulting in 12.1% sensitivity and 0.18 agreements against sputum culture. On the other hand, the sensitivity of RD9-based PCR directly on stool was 69.7% by considering sputum culture as a reference standard. Moreover, RD9-based PCR directly on sputum detected 7(6.0%) individuals who were sputum culture negative for M. tuberculosis.

Conclusion: M. tuberculosis was detected in stool of individuals living with HIV who were negative for sputum smear microscopy and culture. Hence, examination of stool samples alongside with sputum samples increases the detection of PTB in individuals living with HIV.

Citing Articles

Non-sputum-based samples and biomarkers for detection of Mycobacterium tuberculosis: the hope to improve childhood and HIV-associated tuberculosis diagnosis.

Kasule G, Hermans S, Semugenze D, Wekiya E, Nsubuga J, Mwachan P Eur J Med Res. 2024; 29(1):502.

PMID: 39420420 PMC: 11487833. DOI: 10.1186/s40001-024-02092-z.


Stool Xpert MTB/RIF Ultra for TB diagnosis in children: experience from a national scale-up programme.

Kabir S, Choudhury S, Rahman T, Rahman S, Uddin M, Nashra A IJTLD Open. 2024; 1(10):437-442.

PMID: 39398435 PMC: 11467856. DOI: 10.5588/ijtldopen.24.0334.


Comparison of Power Ultrasound and NALC-NaOH Decontamination Methods for Stool Mycobacterial Culture: A Prospective Study.

Tian P, He J, Ling X, Wang Y, Deng Y, Zhang Z Microorganisms. 2024; 12(9).

PMID: 39338473 PMC: 11434331. DOI: 10.3390/microorganisms12091799.


Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study.

Kay A, Vasiliu A, Carratala-Castro L, Mtafya B, Mendez Reyes J, Maphalala N Lancet Microbe. 2024; 5(5):e433-e441.

PMID: 38461830 PMC: 11142891. DOI: 10.1016/S2666-5247(23)00391-9.


Analytical performances of the Xpert MTB/RIF assay using stool specimens to improve the diagnosis of pulmonary tuberculosis in Burkina Faso, a tuberculosis endemic country.

Kabore O, Millogo A, Sanogo B, Birba E, Poda A, Nacro B PLoS One. 2023; 18(7):e0288671.

PMID: 37523357 PMC: 10389731. DOI: 10.1371/journal.pone.0288671.


References
1.
Maynard-Smith L, Larke N, Peters J, Lawn S . Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review. BMC Infect Dis. 2015; 14:709. PMC: 4298952. DOI: 10.1186/s12879-014-0709-7. View

2.
Brudey K, Driscoll J, Rigouts L, Prodinger W, Gori A, Al-Hajoj S . Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006; 6:23. PMC: 1468417. DOI: 10.1186/1471-2180-6-23. View

3.
Barnes P, Bloch A, Davidson P, Snider Jr D . Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991; 324(23):1644-50. DOI: 10.1056/NEJM199106063242307. View

4.
Cordova J, Shiloh R, Gilman R, Sheen P, Martin L, Arenas F . Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis. J Clin Microbiol. 2010; 48(5):1820-6. PMC: 2863910. DOI: 10.1128/JCM.01161-09. View

5.
Brosch R, Gordon S, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K . A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A. 2002; 99(6):3684-9. PMC: 122584. DOI: 10.1073/pnas.052548299. View